Literature DB >> 21390467

[Epidemiology of hepatitis C virus infection].

Tatiana Martins1, Janaína Luz Narciso-Schiavon, Leonardo de Lucca Schiavon.   

Abstract

Hepatitis C is a major cause of chronic liver disease worldwide. There is a significant variation in the prevalence of hepatitis C virus (HCV) infection according to the geographic region studied. These discrepancies reflect not only distinct epidemiological characteristics among the populations, but also differences in the methodologies used for the estimates. Despite scarce data, estimates indicate that Brazil is a country with an intermediate prevalence of HCV infection, ranging from 1% to 2%. The most important risk factors for HCV acquisition include injection drug use, blood product transfusion, organ transplantation, hemodialysis, occupational injury, sexual transmission and vertical transmission. Because there is no vaccine and no post-exposure prophylaxis for HCV, the focus of primary prevention efforts should be identification and removal of the risk factors. In this article we review literature regarding the prevalence of HCV infection, particularly in Brazil. In addition, we discuss the pattern of HCV infection according to the age groups and risk factors for HCV acquisition.

Entities:  

Mesh:

Year:  2011        PMID: 21390467     DOI: 10.1590/s0104-42302011000100024

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  11 in total

1.  Implication of reported viral hepatitis incidence rate change in Hubei Province, China, between 2004-2010.

Authors:  Ying Hu; Chuanhua Yu; Banghua Chen; Lei Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-06-09

Review 2.  Recombinase polymerase amplification as a promising tool in hepatitis C virus diagnosis.

Authors:  Hosam Zaghloul; Mahmoud El-Shahat
Journal:  World J Hepatol       Date:  2014-12-27

3.  Epidemiological aspects of HCV infection in non-injecting drug users in the Brazilian state of Pará, eastern Amazon.

Authors:  Aldemir B Oliveira-Filho; Leila Sawada; Laine C Pinto; Daiane Locks; Santana L Bahia; Jairo A A Castro; Renata B Hermes; Igor Brasil-Costa; Carlos E M Amaral; José Alexandre R Lemos
Journal:  Virol J       Date:  2014-02-25       Impact factor: 4.099

4.  HCV infection through perforating and cutting material among candidates for blood donation in Belém, Brazilian Amazon.

Authors:  Rubenilson Caldas Valois; Luciana Maria Cunha Maradei-Pereira; José Ângelo Barletta Crescente; Aldemir Branco de Oliveira-Filho; José Alexandre Rodrigues Lemos
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Nov-Dec       Impact factor: 1.846

5.  Social determinants and risk behaviors associated with prevalent Hepatitis C and HIV/HCV co-infection among male injection drug users in Nepal.

Authors:  Sampurna Kakchapati; Manju Maharjan; Bir Bahadhur Rawal; Sameer Mani Dixit
Journal:  Arch Public Health       Date:  2017-09-04

6.  Correlation between serology and nucleic acid amplification test in blood donors who are reactive for hepatitis B virus, hepatitis C and human immunodeficiency virus and evaluation of the epidemiological profile of infected people in blood centers in the State of Paraná.

Authors:  Heloise Skiavine Madeira; Claudinei Mesquita da Silva; Neila Cristina Scapini; Leyde Daiane de Peder; Jorge Juarez Vieira Teixeira
Journal:  Saudi Pharm J       Date:  2021-04-24       Impact factor: 4.330

7.  Prevalence of hepatitis C virus genotypes in mashhad, northeast iran.

Authors:  H Vossughinia; LA Goshayeshi; H Rafatpanah Bayegi; H Sima; A Kazemi; S Erfani; S Abedini; LE Goshayeshi; K Ghaffarzadegan; H Nomani; S Amel Jamehdar
Journal:  Iran J Public Health       Date:  2012-09-01       Impact factor: 1.429

8.  Association of killer cell immunoglobulin-like receptor polymorphisms with chronic hepatitis C and responses to therapy in Brazil.

Authors:  Janaina Mota de Vasconcelos; Lizomar de Jesus Maués Pereira Móia; Ivanete do Socorro Abraçado Amaral; Esther Castello Branco Mello Miranda; Louise Yukari Cicalisetakeshita; Layanna Freitas de Oliveira; Lilian de Araújo Melo Mendes; Danuta Sastre; Bruna Pedroso Tamegão-Lopes; Larysse Santa Rosa de Aquino Pedroza; Sidney Emanuel Batista Dos Santos; Manoel do Carmo Pereira Soares; Marialva Tereza Ferreira de Araújo; Camila Lucas Bandeira; Adriana Maria Paixão de Sousa da Silva; Zilene Lameira de Medeiros; Leonardo Sena; Samia Demachki; Eduardo José Melo Dos Santos
Journal:  Genet Mol Biol       Date:  2013-03-04       Impact factor: 1.771

9.  Demographic characteristics and intravenous drug use among hepatitis C patients in the Kota Setar district, Kedah, Malaysia.

Authors:  Wei Leong Tan; Goh Yihui; Muhammad Radzi Abu Hassan
Journal:  Epidemiol Health       Date:  2015-07-10

10.  Characteristics associated with anti-HCV serological markers in prisoners in the state of Paraná, Brazil: a case-control study.

Authors:  Tânia Maria Pazin Marques Silva; Lirane Elize Defante Ferreto; Franciele Ani Caovilla Follador; Ana Paula Vieira; Roberto Shigueyasu Yamada; Léia Carolina Lucio; Joana Perotta Titon; Renata Himovski Torres; Greicy Cézar do Amaral; Harnoldo Colares Coelho
Journal:  Braz J Infect Dis       Date:  2019-06-20       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.